Clinical Research Directory
Browse clinical research sites, groups, and studies.
Feasibility Study of Sentinel Navigation Surgery in Early Gastric Cancer Using Fluorescence (SENORITA4)
Sponsor: National Cancer Center, Korea
Summary
SENORITA 1 trial showed laparoscopic sentinel lymph node biopsy and stomach preserving surgery in early gastric cancer can increase the quality of life. (Ryu KW et al. JCO 2022) The radioactive isotope is difficult to use because of the hazard of radiation and shortage of materials. The aim of this study is to investigate whether laparoscopic sentinel lymph node biopsy and stomach-preserving surgery using only fluorescence is feasible.
Official title: Feasibility Study of Sentinel Navigation Surgery in Early Gastric Cancer Using Fluorescence (SENORITA4 Trial)
Key Details
Gender
All
Age Range
20 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
203
Start Date
2023-08-17
Completion Date
2030-12-31
Last Updated
2023-08-07
Healthy Volunteers
No
Conditions
Interventions
Laparoscopic sentinel navigation surgery using fluorescence
If the frozen biopsy of sentinel lymph nodes are all negative using fluorescence, stomach-preserving surgery is performed
Locations (7)
Dongnam Inst. of Radiological & Medical Science
Busan, Gijang-gun, South Korea
Gyeongsang National University Hospital
Gyeongsang, Gingu-si, South Korea
Sevrance Hospital
Seoul, Sinchon, South Korea
Ajou University Medical Center
Gyeonggi-do, Suwon-si, South Korea
Gyeongsang National University Changwon Hospital
Changwon, South Korea
Samsung Medical Center
Seoul, South Korea
Soon Chun Hyang University Hospital Bucheon
Seoul, South Korea